UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT

Bone marrow transplantation (Basingstoke), 2021-02, Vol.56 (2), p.334-346

2021

Volltextzugriff (PDF)

The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation

Annals of hematology, 2020-10, Vol.99 (10), p.2393-2404

2020

Volltextzugriff (PDF)

Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study

Cancer medicine (Malden, MA), 2023-09, Vol.12 (17), p.17808-17821

2023

Volltextzugriff (PDF)

Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation

Annals of hematology, 2020-08, Vol.99 (8), p.1873-1882

2020

Volltextzugriff (PDF)

The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia

Leukemia research reports, 2020-01, Vol.13, p.100198-100198, Article 100198

2020

Volltextzugriff (PDF)

Mutation profiles of diffuse large B‐cell lymphoma transformation of splenic B‐cell lymphoma/leukemia, unclassifiable on whole‐exome sequencing

EJHaem, 2021-11, Vol.2 (4), p.854-860

2021

Volltextzugriff (PDF)

Central nervous system infection following allogeneic hematopoietic stem cell transplantation

Hematology/oncology and stem cell therapy, 2017-03, Vol.10 (1), p.22-28

2017

Volltextzugriff (PDF)

Mesenchymal stem cells for treatment of graft-versus-host disease

Rinshō ketsueki, 2017, Vol.58 (12), p.2440

Najima, Yuho

2017

Volltextzugriff (PDF)

Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice

Proceedings of the National Academy of Sciences - PNAS, 2010-07, Vol.107 (29), p.13022-13027

2010

Volltextzugriff (PDF)

Outcomes of Haploidentical Salvage Transplantation Using Post-Transplant Cyclophosphamide for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation

Blood, 2021-11, Vol.138 (Supplement 1), p.2871-2871

2021

Volltextzugriff (PDF)

Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission

Blood, 2021-11, Vol.138 (Supplement 1), p.3380-3380

2021

Volltextzugriff (PDF)

Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Blood, 2021-11, Vol.138 (Supplement 1), p.3692-3692

2021

Volltextzugriff (PDF)

Donor‐derived gene mutations in sex chromosome loss after stem cell transplantation

British journal of haematology, 2021-11, Vol.195 (3), p.e142-e146

2021

Volltextzugriff (PDF)

Clinical, Cytogenetic, and Molecular Characteristics Analysis in Myelodysplastic Syndromes with Elevated Ferritin Levels

Blood, 2021-11, Vol.138 (Supplement 1), p.4664-4664

2021

Volltextzugriff (PDF)

The Authors' Reply to "The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome"

Internal Medicine, 2019, pp.2793-19

2019

Volltextzugriff (PDF)

Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1/FLT3-ITD Genotypes in Patients with Acute Myeloid Leukemia

Blood, 2022-11, Vol.140 (Supplement 1), p.8914-8916

2022

Volltextzugriff (PDF)

Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission

Annals of hematology, 2019-07, Vol.98 (7), p.1799-1801

2019

Volltextzugriff (PDF)

Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial

Blood, 2021-11, Vol.138 (Supplement 1), p.1477-1477

2021

Volltextzugriff (PDF)

Combining the Number of Infectious Episodes and Interval of Chemotherapy to Transplantation May Predict a Transplant Outcome in Patients with Acute Myeloid Leukemia: A Retrospective Analysis of JALSG AML201 Study

Blood, 2018-11, Vol.132 (Supplement 1), p.4643-4643

2018

Volltextzugriff (PDF)

Clinical Efficacy of Prebiotics on Transplant-Related Complications

Blood, 2018-11, Vol.132 (Supplement 1), p.4573-4573

2018

Volltextzugriff (PDF)

Presence of TP53 Mutation and Monosomal Karyotype Predict the Outcome of Patients with Acute Myeloid Leukemia in Non-Remission at Allogeneic Stem Cell Transplantation

Blood, 2018-11, Vol.132 (Supplement 1), p.2168-2168

2018

Volltextzugriff (PDF)

Clonal Dynamics and Publicness of CMV-Specific TCR Repertoire after Allogeneic Stem Cell Transplantation

Blood, 2019-11, Vol.134 (Supplement_1), p.4551-4551

2019

Volltextzugriff (PDF)

Clinical and Genetic Features of Constitutional Partial Trisomy 8 Mosaicism (CT8M) Patients with Cytopenia

Blood, 2019-11, Vol.134 (Supplement_1), p.5413-5413

2019

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(65)
Berichte
(7)

Sprache

Englisch
(58)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Male
(11)
Middle Aged
(11)
Hematopoietic Stem Cell Transplantation
(10)
Acute Myeloid Leukemia
(5)
Adult
(5)
Allogeneic Hematopoietic Stem Cell Transplantation
(5)
Bone Marrow Transplantation
(5)
Female
(5)
Hematology
(5)
Retrospective Studies
(5)
Stem Cell Transplantation
(5)
Stem Cells
(5)
Transplantation, Homologous
(5)
Aged
(4)
Mutation
(4)
Oncology
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Chronic Myeloid Leukemia
(3)
Fatal Outcome
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT

The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation

Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study

Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation

The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia

Mutation profiles of diffuse large B‐cell lymphoma transformation of splenic B‐cell lymphoma/leukemia, unclassifiable on whole‐exome sequencing

Central nervous system infection following allogeneic hematopoietic stem cell transplantation

Mesenchymal stem cells for treatment of graft-versus-host disease

Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice

Outcomes of Haploidentical Salvage Transplantation Using Post-Transplant Cyclophosphamide for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission

Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Donor‐derived gene mutations in sex chromosome loss after stem cell transplantation

Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT)

Clinical, Cytogenetic, and Molecular Characteristics Analysis in Myelodysplastic Syndromes with Elevated Ferritin Levels

The Authors' Reply to "The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome"

Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1/FLT3-ITD Genotypes in Patients with Acute Myeloid Leukemia

Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Myeloablative Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT)

Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission

Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial

Combining the Number of Infectious Episodes and Interval of Chemotherapy to Transplantation May Predict a Transplant Outcome in Patients with Acute Myeloid Leukemia: A Retrospective Analysis of JALSG AML201 Study

Clinical Efficacy of Prebiotics on Transplant-Related Complications

Presence of TP53 Mutation and Monosomal Karyotype Predict the Outcome of Patients with Acute Myeloid Leukemia in Non-Remission at Allogeneic Stem Cell Transplantation

Clonal Dynamics and Publicness of CMV-Specific TCR Repertoire after Allogeneic Stem Cell Transplantation

Clinical and Genetic Features of Constitutional Partial Trisomy 8 Mosaicism (CT8M) Patients with Cytopenia

Aktive Filter

Suchergebnisse filtern